55 /100
HIGH RISK
Score updated Jul 14, 2026

GNS — Genius Group Limited Dilution Risk Tracker

Track GNS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GNS — Get alerts when the score changes →

As of July 14, 2026, Genius Group Limited (GNS) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. Genius Group Limited has a market capitalization of $49.53M, 159.84M shares outstanding, 18 institutional holders tracked. Key dilution vectors include shelf registration capacity of $6.00B, ATM program capacity of $8.00M, 38.65M outstanding warrants.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
40
📊 Float Risk
12
⚠️ Warrant Exposure
70
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
47%
🔄 Reverse Split 55%
• 50-day avg $0.31 below $1 exchange minimum
📜 Warrant Exercise 40%
• Significant warrants: 24% of shares outstanding
• Elevated warrant risk score (70/100)
💰 Capital Raise 38%
• Active shelf registration ($6000M, 12115% of market cap)
• Active ATM program with $8M remaining capacity
🔔 Track GNS — Get forecast alerts →

💹 Market Data

Market Cap$49.53M
Shares Outstanding159.84M
Float143.95M
Cash$2.47M
Debt$27.63M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 27.0% shares (2026Q1 vs prior)
18 institutional holders · 563.6K shares
#1 XTX Topco Ltd 269.3K shares
#2 TWO SIGMA SECURITIES, LLC 38.8K shares
#3 HRT FINANCIAL LP 36.4K shares
+ 15 more holders Sign up free to view →

📉 Short Interest

Short Interest8.47M
Days to Cover1.2
% of Float5.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

6-K 8K EVENT May 04, 2026
F-3/A SHELF May 04, 2026
F-3 SHELF May 01, 2026
6-K 8K EVENT Apr 22, 2026
424B5 ATM Apr 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for GNS Shareholders

Genius Group Limited (GNS) has a DilutionScore of 55/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

The most significant dilution vector for GNS is its shelf registration capacity of $6.00B. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely. GNS has an active ATM (at-the-market) program with $8.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for GNS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for GNS alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding Shelf Registrations → How ATM Offerings Work → Warrants Explained →
Track GNS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GNS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for GNS
📊 GNS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GNS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.